• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Availability of Novartis Animal Health products remains limited

September 25, 2012

Manufacturer assures veterinarians, pet owners that production and distribution of popular brands will resume.

Pet owners hoping to refill their pets’ supply of Sentinel or Interceptor flavor tabs may have to wait a bit longer. Novartis Animal Health, the company responsible for manufacturing these parasiticides, recently issued a statement that while production, packaging and shipping of one of its products, Clomicalm, has resumed at its Lincoln, Neb., facility, full-scale production and shipment are still pending for others, including Interceptor flavor tabs, Sentinel flavor tabs, Deramaxx, Program tablets and suspension, and Milbemite. Novartis hasn’t provided exact dates for shipping these remaining products, but reassures veterinarians and consumers that “our robust team of staff and consultants is working hard to ensure that normal production resumes as soon as is practically possible.”

In late December 2011, Novartis announced that production and distribution of all products made at the Lincoln facility would temporarily cease in order to address system and process upgrades at the site. Although the company stated that the move to close its facility was voluntary, it became apparent that the U.S. Food and Drug Administration (FDA) had a hand in shutting operations down. Reports released after onsite inspections in 2011 and posted on the FDA's website cited multiple failures in quality assurance and control, including evidence of foreign objects and chipped or cracked product in drug containers and suspected package tampering.

A few months later, in February 2012, the company notified consumers that it would resume distribution and sale of products that had already been manufactured at the Lincoln plant and assured veterinarians and pet owners that they would closely monitor the newly released inventory. However, product supplies quickly dwindled and many of the products have since been backordered, disrupting sales and disappointing pet owners at veterinary clinics nationwide. Making matters worse, the company also received complaints that some of the products—ones that veterinary customers have been told are in short supply—have been showing up in certain retail chain and online stores.

Advertisement

Novartis again reached out to consumers in August 2012 with a letter acknowledging the frustration that pet owners are currently experiencing and requesting that veterinarians save room for the return of its products. The letter from Vice President Andy Ferrigno states, “While we understand your need to do what is right for your business, patients and clients, we hope you will seriously consider saving us a spot on your shelves—we politely ask that you give your Novartis sales representative a chance to earn back your business and not unnecessarily “load” your shelves before year end.”

Related Content:

Breaking NewsClient Relations & Marketing
Treating patients with spectrum of care in mind
Treating patients with spectrum of care in mind
 BluePrints Veterinary Marketing Group awarded 2 Gold VETTY Awards
BluePrints Veterinary Marketing Group awarded 2 Gold VETTY Awards
3 tips for marketing veterinary dental services
3 tips for marketing veterinary dental services

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement